1) Clostridium botulinum occurs in the soil and it is the cause of botulism.

2) Clostridium botulinum is gas production.

3) For example, they can produce anthrax and botulinum toxin.

4) Clostridium botulinum may produce any of neurotoxinA ~ G ,[http:///botulinum.html] which are the most toxic bacterial proteins known.

5) Ingredients: vegetal botulinum, rice germ oil, HA, vitamin C, collagen.

6) Botulinum toxin was injected into the masseter muscle and temporal muscle in the experimental group.

7) Some of them needed botulinum toxin injections in the pretarsal part of orbicularis oculi muscles.

8) Objective To observe the clinical effects of Botulinum toxin A(BTX-A) injection on children with spastic diplegia.

9) AIM: To explore the effects of botulinum toxin A in improving the abduction activity of carpometacarpal joint of thumb and spasm in spastic cerebral palsy patients with adduction deformity thumb.

10) Objective:To investigate the effect and mechanisms of botulinum toxin type A(BTA)on vasomotor rhinitis.

11) The known adverse effects related to botulinum A toxin injection have achieved little attention.

12) Objective To explore the contamination of Clostridium botulinum in the soil of Shijiazhuang, and to provide a scientific basis for preventing, diagnosing and treating food-borne botulism.

13) ObjectiveTo evaluate the effects of Botulinum toxin type A(BTX-A) repeated injection into detrusor to treat detrusor hyperreflexia and neurogenic incontinence in spinal cord injury(SCI) patients.

14) Botox, the commercial name of botulinum toxin type A, is a neuro-toxin produced by Clostridium botulinum. It can block the signals that make your muscles move.

15) The potentency of the toxIn from Clostridium botulInum is sufficient to create 65 % fatality In humans who Ingest the toxIn.

16) Injectable fillers and botulinum toxin are suitable for people with busy lifestyles who do not want the inconvenience of a long recovery.

17) Objective To investigate the curative effects of botulinum toxin type A on hemifacial spasm.

18) Objective : To investigate the efficacy botulinum toxin A in the treatment of hemifacial spasm and blepharospasm.

19) Objective: To present the cosmetic use of botulinum A toxin in treatment of dynamic facial lines.

20) Since then, several studies have evaluated botulinum toxin as a migraine preventative.

21) The rat is the unacceptable face of the environment; so is listeria and clostridium botulinum.

22) Every 13 weeks Beck receives 300 units of the botulinum toxin, which reaches peak effect in about five weeks.

23) The only bacteria known to be spread by food in 1950 were Clostridium botulinum, Staphylococcus aureus and Salmonella.

24) In general, these microorganisms have less thermal resistance than Clostridium botulinum and require less - severe thermal processes.

25) Objective : To compare effectrelaxation of spasticity in cerebral palsy by Botulinum Toxin A and phenol block.

26) Around 1820, the German doctor Justinus Kerner described botulin toxin as "sausage poison", because the deadly Clostridium botulinum bacterium is often found in meat products.

27) Objective To observe the clinical effect of blepharospasm and facial spasm with botulinum toxin A.

28) Nisin has low toxicity to human and inhibits growth of botulinum and Listeria monocytogenes.

29) Objective : To study the long term therapeutic effects of botulinum toxin type A on hemifacial spasm.

30) Objective To observe the clinical efficacy and safety of pericranial intramuscular administration (PIA) of botulinum toxin A (BTXA) in patients with tension type headache (TTH).

31) This is because some micro-organisms and spores are particularly resistant to radiation. They include the most serious food poisoning micro-organism , Clostridium, botulinum.

32) Therefore, even if the normal processing of honey, there is also a certain number of Clostridium botulinum spores exist.

33) Objective To explore the effects of using different doses of Botulinum Toxin Type A(BTX-A)in the treatment of masseteric hypertrophy.

34) The two most toxic chemicals for humans, that we know of, are botulinum toxin and tetanospasmin.

35) Conclusions Botulinum toxin type A local injection is a safe, effective, simple and easy means for the treatment of facial muscle dystonia.

36) Botulinum toxins produced by Clostridium botulinum are neurotoxins and cause flaccid paralysis as a result ofinhibition of acetylcholine release at the neuromuscular junction.

37) Botulism is a rare and dangerous infection caused by a soil germ called Clostridium botulinum which can contaminate canned or bottled foodstuffs and survive in them.

38) Remain vigilant for systemic effects that may follow administration of botulinum toxins, including dysphagia, dysphonia , weakness, dyspnea[http://], or respiratory distress.

39) Objective : To study the efficacy of botulinum A toxin injections for the treatments of blepharospasm.

40) Intraprostatic Botulinum Toxin Type A injection in patients with benign prostatic enlargement: duration of the effect of a single treatment.

41) Follow-up evaluations were at 4 and 12 weeks after injection, when the study was unblended , with further follow-up in the botulinum toxin type A group at 24 weeks.

42) Methods: Botulinum A toxin was injected for treatment of dynamic facial lines.

43) Eating food contaminated with Clostridium botulinum can lead to serious food poisoning (the fatality rate is 5 to 10%) if there is toxin present.

44) Objective To investigate the use of botulinum toxin (BTX) A in the treatment of palatal myoclonus objective tinnitus (PMOT).

45) Clostridium botulinum is the name of a group of bacteria commonly found in soil.

46) Botox is the marketing name given to a neurotoxin called botulinum toxin A.

47) Methods According to landform, 8 counties (cities or districts) were chosen evenly to collect different types of soil for testing Clostridium botulinum.

48) Objective To study the effects of botulinum toxin A(BTX -A)intramuscular injection and comprehensive rehabilitation on correcting the cerebral function deformity in cerebral palsy(CP).

49) Chapman reports that it has identified the cellular receptor for botulinum neurotoxin A.

50) Botox is the trade name for botulinum toxin – a protein produced by the Clostridium botulinum bacterium.

51) Botulinum A toxin has been widely applied to the treatment of muscular hypertonicity for many different functional systems of the human body.

52) Aim: In order to learn nucleotide sequences of Clostridium botulinum neurotoxin type A(BoNT/A) and deduce its amino acid sequences, the authors analyzed the gene of the toxin .

53) The results revealed that all of the 20 strains of Clostridium botulinum type A were positive and the others were all negative in PCR.

54) Intradermal injection of botulinum A toxin has recently been found to be a safe and effective alternative in the adult population.

55) In January, Bao Ding Seafood of New York issued a recall on their Boiled Horse Mackerel product because of its potential contamination with the clostridium botulinum bacterium that causes Botulism.

56) ObjectiveTo investigate the effect of injecting botulinum toxin A ( BTA ) in patients with congenital nystagmus ( CN ).

57) We describe two cases of granular parakeratosis. In case one, the lesions cleared rapidly and completely after botulinum toxin injections to the axillae and groins.

58) Botox, the commercial name of botulinum toxin type A, is a neuro-toxin produced by Clostridium botulinum.

59) ObjectiveTo investigate the effect of injecting botulinum toxin A ( BTA ) in patients congenital nystagmus ( CN ).